14.86 CAD

Opening hours: 09:30 - 16:00 (Eastern Standard Time: 11/23/2024 9:04:28 AM)
Exchange closed, opens in 2 days
2.77 CAD (2.77%)
4.13 CAD (4.13%)
-17.40 CAD (-17.40%)
73.40 CAD (73.40%)
139.29 CAD (139.29%)
1,108.13 CAD (1,108.13%)
-4.99 CAD (-4.99%)
639.30 CAD (639.30%)

About Cipher Pharmaceuticals Inc

Market Capitalization 371.05M

Cipher Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. It offers Epuris (isotretinoin), an oral retinoid indicated for the treatment of severe nodular and/or inflammatory acne, acne conglobate, and recalcitrant acne; Actikerall, a topical solution indicated for the treatment of slightly palpable and/or moderately thick hyperkeratotic actinic keratosis (Grade I/II) of the face, forehead, and balding scalp; Ozanex for the topical treatment of impetigo; Vaniqa, a topical cream for the slowing of the growth of unwanted facial hair in women; Durela, an opioid analgesic for the management of moderate to moderately severe pain in adults; Brinavess for the rapid conversion of onset atrial fibriallation to sinus rhythm in adults; and Aggrastat, a reversible GP IIb/IIIa inhibitor for use in patients with Acute Coronary Syndrome. The company's licensed products comprise Absorica, an oral retinoid indicated for the treatment of f severe nodular and/or inflammatory acne, acne conglobate and recalcitrant acne; Lipofen, which is indicated as adjunctive therapy to diet to reduce elevated LDL-C, total-C, triglycerides, and Apo B, and to increase HDL-C, as well as to reduce triglycerides in adult patients; and Conzip, an opioid agonist indicated for the management of moderate to moderately severe chronic pain in adults. Its pipeline products include MOB-015, a topical formulation of terbinafine, which is in phase 3 clinical trial for treatment of onychomycosis; CF-101 (Piclidenoson) that is in phase 3 clinical trial for severe plaque psoriasis and rheumatoid arthritis; and DTR-001, a tattoo removal cream, which is in pre-clinical stage. Cipher Pharmaceuticals Inc. was founded in 2000 and is headquartered in Mississauga, Canada.

Headquarters (address)

5750 Explorer Drive

Mississauga L4W 0A9 ON

Canada

Phone905 602 5840
Websitehttps://www.cipherpharma.com
Employees0
SectorHealthcare
IndustryDrug Manufacturers Specialty & Generic
TickerCPH
ExchangeToronto Stock Exchange
CurrencyCAD
52 week range5.35 - 19.69
Market Capitalization371.05M
P/E trailing16.29
P/E forward12.72
Price/Sale14.02
Price/Book3.75
Beta1.17
EPS0.890
EPS Canada (ID:82, base:722) 1.84

CleverShares.com|
2024 ©

1.0.9092.25789